| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.6M | — | +56.6% |
| Cost of Revenue | $11.2M | — | +29.1% |
| Gross Profit | $16.4M | — | +83.2% |
| R&D Expense | $10.4M | — | +36.4% |
| SG&A Expense | $9.6M | — | +45.2% |
| Operating Income | -$24.3M | — | -30.2% |
| Net Income | -$21.9M | — | +23.6% |
| EPS (Basic) | -$0.49 | — | +47.3% |
| EPS (Diluted) | -$0.49 | — | +47.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.2M | -4.3% | -28.9% |
| Short-term Investments | $169.3M | -9.7% | -10.4% |
| Accounts Receivable | $15.8M | -8.0% | +73.8% |
| Inventory | $23.7M | +9.2% | +50.8% |
| Current Assets | $248.0M | -7.4% | -5.3% |
| Total Assets | $304.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.8M | — | -19.3% |
| Capital Expenditures | $1.4M | — | +313.5% |
| Investing Cash Flow | $21.8M | — | +112.2% |
| Financing Cash Flow | $623K | — | -99.7% |
| Free Cash Flow | -$25.2M | — | -24.1% |
| -9.9% |
| Current Liabilities | $23.2M | -25.0% | +40.6% |
| Total Liabilities | $33.2M | -19.4% | +36.7% |
| Stockholders' Equity | $271.2M | -5.7% | -13.5% |